本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
HONG KONG, Nov. 21, 2025 /PRNewswire/ -- The modern workday has outgrown traditional ergonomic office chairs. With remote workers, creatives, and gamers now spending more time sitting than any previous generation, sedentary strain has become a modern health crisis. Studies indicate that more than 60% of professional workers sit for over six hours a day, leading to increased spinal pressure, chronic fatigue, and long-term musculoskeletal pain. LiberNovo_BFCM Today, LiberNovo announces its Black Friday Cyber Monday (BFCM) 2025 campaign, with a focus on its flagship product, the LiberNovo Omni, the world's first dynamic ergonomic office chair designed to actively respond to the body's natural movement. The November 20 announcement marks the brand's largest U.S. and Canada push to date. Built for the Six Roles Most Affected by Sedentary Work Coders, editors, remote workers, or anyone working on a screen or gaming for long hours experience the same issue: static sitting. The effects do not discriminate: Programmers & creative professionals: Persistent neck and lumbar strain from long hours of forward focus. Gamers: Extended fixed postures can cause shoulder fatigue and lower back compression. Remote workers: Make-shift home setups that offer insufficient support. Health-driven consumers: Seeking active alternatives to static office seating. Users already living with pain: Needing real, structural relief—not more cushions. LiberNovo's response is a smarter sitting solution, a movement built around the belief that people shouldn't have to choose between long hours and long-term health. Dynamic Support: Ending the Era of Static Ergonomics Static chairs force the body to adapt to fixed angles. Omni evolves static sitting into something more organic. With Dynamic Support, a synchronized system that connects the backrest, seat, armrests, and Neck Support, the chair automatically readjusts to support the body naturally through every shift and movement while sitting. You choose the angle, and Omni maintains continuous alignment. Its Bionic FlexFit Backrest uses 16 pivot points and eight adaptive panels to mimic the spine's natural movement. Unlike conventional chairs that support only one position, FlexFit maintains support across all of them. The result is a fully responsive ergonomic office chair designed for the modern work environment. Tailored Modes for Modern Workflows To support the requirements of the workday's daily rhythm, the LiberNovo Omni offers four functional recline modes: 105° Deep Focus Mode: upright presence for calls and collaboration. 120° Solo-Work Mode: optimal for focused sessions, easing spinal pressure without disengagement. 135° Soft-Recline Mode: relaxed but locked-in, reduces long-term muscle tension and encourages natural movement. 160° Spine Flow Mode: a deep recline engineered for spinal decompression and post-work restoration. For users seeking relief from stiffness or tension, OmniStretch serves as an at-home recovery tool, particularly beneficial for those already experiencing back pain due to prolonged periods of sitting. Designed for the Realities of U.S. & Canadian Work Life Since launching its North American warehouse network, LiberNovo has experienced rapid adoption among developers, tech workers, and creative professionals across the U.S. and Canada. As hybrid schedules intensify, the need for a reliable ergonomic chair to alleviate back pain has become more urgent than ever. Omni addresses that need with structural engineering rather than accessories: 4D adjustable armrests for proper desk alignment 3D height-adjustable Neck Support Two-level ergonomic footrest options, accommodating users from 153cm to 180+ cm, seeking a proper ergonomic office chair with a footrest Angled seat base that stabilizes the pelvis and maintains posture during long sessions BFCM Event Details (U.S. & Canada) Event Window United States (PST): Nov 10, 08:00 – Dec 5, 08:00 Canada (EST): Nov 10, 11:00 – Dec 5, 11:00 Highlights Up to 34% off flagship models for the Black Friday–Cyber Monday peak. Holiday Bundle options include Standard, Pro, and Deluxe. Orders over $800 or C$1,200 qualify for a prize-wheel spin, with rewards ranging from accessories to a top prize of a full refund of the order cost. VIP members receive double loyalty points during the BFCM window. The campaign marks LiberNovo's biggest North American sales promotion. EU/DE/UK regions will begin full in-stock availability on December 20. Reimagining How Sitting Should Be "Sit Well, Live Better" is LiberNovo's direction for the next decade. As work and play continue to shift toward digital spaces, the company aims to make dynamic ergonomics the new standard, redefining what the best ergonomic chair should offer: motion, alignment, and comfort that keep you moving. Final Call With Black Friday entering its final stretch through December 5, LiberNovo encourages creatives, gamers, remote workers, and anyone living with pain to upgrade during the most cost-effective window of the year. More information is available at libernovo.com.
Education Cannot Wait 與 Save the Children 宣佈攜手合作，並與 Arup 以及 World Wildlife Fund 組成聯盟，共同為環保型臨時學習空間制定全新標準。 紐約2025年11月20日 /美通社/ -- 隨著氣候變遷加劇，全球危機的規模與嚴重性有增無減，Education Cannot Wait (ECW) 宣佈向救助兒童會 (Save the Children) 提供 65 萬美元加速基金補助，並與工程顧問 Arup 以及世界自然基金會 (WWF) 組成聯盟，為危機環境中的臨時學習空間制定全新綠化標準。正當世界領袖齊聚 COP30 聯合國氣候變化大會，致力加速推動解決方案，以實現更可持續、更具韌性的未來，這項倡議彰顯出氣候行動與緊急情況下教育之間的重要關聯。 一位年輕的羅興亞女孩在孟加拉 Cox’s Bazar 的一個臨時學習中心參加課程，這是世界上最大的難民營的所在地。© ECW 臨時學習空間，為身陷緊急狀況的兒童提供生命支援：從孟加拉國的難民營，以至南蘇丹的洪水區。然而該領域缺乏明確指引，未能說明如何以環保、韌性且包容的方式設計、建造及管理這些設施。缺乏適當標準，將導致資源浪費與環境日趨惡化，進而降低學習環境的質素。 為填補此缺口，本項補助計劃匯聚了救助兒童會於兒童權利與緊急救援領域的領導地位、 Arup 的技術專長，加上世界自然基金會深厚的環境知識，透過創新合作模式，將人道救援、工程技術與生態可持續性緊密連結起來。 救助兒童會「學習突破」全球教育總監 Marian Hodgkin 表示：「我們的臨時學習空間在危機中提供穩定與希望，而這份希望必須超越當下困境，支持長遠的穩定發展，故此我們必需將專業技術與兒童心聲相結合。當兒童參與塑造這些空間時，我們正在使學習空間變得更安全、更切合實際需求且更具包容性。透過確保這些學習空間能夠承擔環保責任與具備韌性，我們向孩子們展示：我們正為其未來作出投資。」 Arup 副總監兼 UKIMEA 教育業務負責人 Hayley Gryc 表示：「Arup 很榮幸能與救助兒童會及世界自然基金會合作，這要歸功於 Education Cannot Wait 行動的支援，為危機中的兒童打造安全、可持續且能夠適應不同氣候的環境。這項計劃是重新構思教育與氣候行動如何融合的重要一步，確保即使在世界上最具挑戰性的環境中，臨時學習空間也能同時維護人類尊嚴與環境責任。」 「臨時學習空間，是災後幫助兒童重拾日常生活的避風港。但若未將環境因素納入設計考量，我們恐將加劇社區面臨的極端災害挑戰——諸如洪水、地震與火災等災難帶來的困境。透過這項合作夥伴關係，我們正開發實用工具，讓每個處於危機中的教室更具韌性、更包容，更綠意盎然。」世界自然基金會環境和災難管理高級總監 Anita van Breda 表示。 此項計劃面向在危機地區運作的教育工作者，將為其開發、試行並分享實用且易於操作的工具。該指引涵蓋臨時學習空間整個生命週期（從設計與材料採購到維護與退役），重點在於低衝擊施工與易於融入當地社會。指引同時亦著重納入身心障礙兒童及面臨性別障礙的兒童。 我們將與本地及國際夥伴共同建立全球臨時學習空間綠化框架，並配套實用指南與成本核算工具。此框架將在不同危機環境中進行測試，確保其在緊急情況下依然適用。這些工具將透過教育、氣候及人道主義網絡公開分享，以促進廣泛採用並產生深遠影響。 此項補助金，是 ECW 對緊急情況下作出之氣候智能教育戰略承諾的一環。此計劃彰顯出集體投資教育是氣候行動關鍵支柱，形勢迫切，也呼應了第 30 屆聯合國氣候變化大會 (COP30) 的行動呼籲，並為全球貢獻改革力量——在日益加劇的氣候與人道風險中，使教育體系更具韌性、可持續性與包容性。
報告就今年作物收成情況，向全球及國內客戶提出展望建議。 曼尼托巴省溫尼伯2025年11月20日 /美通社/ -- Cereals Canada 今天向國內和全球的加拿大小麥客戶發佈了《全新小麥農作物報告》(New Wheat Crop Report)。該報告涵蓋加拿大 2025 年小麥產季的製粉性能、麵粉/粗粒麵粉品質，以及終端產品功能性等相關資訊。 Cereals Canada 2025 年農作物摘要 (2025 Crop Summary) 行政總裁 Dean Dias 表示：「加拿大生產了另一種具有良好功能的高質量小麥作物。加拿大正在成為第三大小麥出口商，也是高品質高蛋白小麥的第一出口商。2025 至 2026 年間，預計將有 2,740 萬公噸小麥運抵全球超過八十個國際市場，其品質與蛋白質含量均符合客戶預期標準。 2025 年，加拿大農民種植了 3,660 萬公噸小麥，其中多數品質等級為一等或二等。 儘管草原地區的生長條件變化多端，但盛夏時節適時的降雨使收成高於平均水準。在加拿大東部地區，冬小麥整個生長季的氣候條件良好，造就了豐碩的產量與優良的品質。 小麥蛋白質含量與平均水平相當。 2025 年產季的所有小麥等級均具備優良的容重，且所有西部混合樣本的千粒重均高於平均值。 今年，作為新穀物推廣計劃的一環，Cereals Canada 將與二十九個國家展開合作，這些國家在 2024 年共採購了價值 82 億美元的加拿大小麥。該機構將攜手價值鏈成員、生產者代表及加拿大穀物委員會 (Canadian Grain Commission; CGC)，於 11 月 18 日及 19 日舉辦兩場客戶網絡研討會，正式發佈 2025 年小麥作物的科技數據。 Cereals Canada 透過其收成評估計劃生成《2025 年全新小麥農作物報告》(2025 New Wheat Crop Report) 數據，該計劃傳統上僅涵蓋加拿大西部的小麥產量。今年，該機構透過與安大略省穀物農民協會 (Grain Farmers of Ontario) 的合作，首次對東部小麥品種進行了評估。 技術服務副主席 Elaine Sopiwnyk 表示：「這對 Cereals Canada 而言是具有里程碑意義的一年有機會分析來自全國各地的小麥樣本，不僅拓展了技術團隊的專業知識，更有效簡化了今年《全新小麥農作物報告》(New Wheat Crop Report) 的編製流程。」 《全新小麥農作物報告》(New Wheat Crop Report) 每年發佈一次，由 Cereals Canada 委員會 (CGC)、價值鏈成員和各省種植者委員會攜手編制並發佈。整個收穫季期間，加拿大穀物協會與出口商及安大略省穀物農會合作，從亞伯達省、薩斯喀徹溫省、曼尼托巴省及安大略省採集具代表性的樣本，涵蓋加拿大西部紅春麥 (CWRS)、加拿大西部琥珀杜蘭麥 (CWAD)、加拿大東部軟紅冬麥 (CESRW) 以及符合特定規格的小麥。 加拿大《2025 年全新小麥農作物報告》(2025 New Wheat Crop Report) 可於以下網址下載：cerealscanada.ca/2025-new-crop-report/。 Cereals Canada 簡介：Cereals Canada 是代表加拿大榖物價值鏈的全國非牟利行業協會。我們重視聯繫，並會與政府和持份者合作，供應適時且專業的技術資料，以提供最佳客戶體驗。我們致力支援加拿大榖物價值鏈，當中包括農民、出口商、開發商、加工商以及我們的全球客戶，同時關注貿易、科學和可持續發展。 Cereals Canada 行政總裁 Dean Dias 如需更多資訊，請聯絡：Ellen Pruden，傳訊及價值鏈關係部副總裁，電郵：epruden@cerealscanada.ca，手提電話：204-479-0166
馬耳他聖朱利安斯2025年11月20日 /美通社/ -- GEDU Global Education 旗下院校 GBS Malta 今日宣佈，隨著首屆畢業生正式投身職場，將為當地經濟注入新動力。 馬耳他總理 Robert Abela 典禮由馬耳他總理 Robert Abela 擔任主禮嘉賓，馬耳他商界領袖及外交界高層亦有出席見證。 本屆畢業生中，修讀人數最多的為項目管理工商管理碩士 (MBA) 課程，該課程現已獲項目管理協會 (APM) 認證。GBS Malta 的課程日益受歡迎。這不僅歸功於馬耳他的優質生活，更因該國經濟強勁增長所帶來的就業機遇——除旅客量高企外，島上各地的私營機構投資亦相當龐大。 若馬耳他要維持此積極發展軌跡，優質的高等教育至關重要。 馬耳他總理 Robert Abela 在典禮上談及學生的成就時表示： 「這反映了馬耳他已蛻變成一個集優質教育與理想事業發展階梯於一身的活力樞紐。 在瞬息萬變的世界中，這些技能讓學生能把握先機。 GBS Malta 支持本地教育、就業及社會發展，展現了對我們社區的真誠承諾。」 GBS Malta 歐洲營運總監 Allen Lofaro 形容，這對學院而言是極具意義的一天。 Lofaro 先生表示：「看到學生今天畢業，我深感自豪。深信他們將在馬耳他以至全球各地發揮影響力。 現時投身馬耳他教育界令人振奮，我們亦很榮幸獲得總理的支持。馬耳他吸納及挽留年輕人才的能力日益提升——他們在這個國家看到了樂觀及長遠的未來。 這有助馬耳他發展成教育樞紐，吸引來自世界各地有抱負的學生和院校。 本島的知識型經濟蓬勃發展，GBS 將繼續發揮作用，加以鞏固。我們的課程設計迎合行業需求，特別是高科技及高增長領域。 今天的畢業生只是首批，未來將有更多學子接棒，我熱切期待他們未來的成就。」 GBS Malta 簡介： GBS Malta 為高等教育機構，隸屬全球教育機構 Global Education (GEDU)。GEDU 為領先業界的組織，為全球 15 個國家的 80,000 名學生提供優質教育。 GBS Malta 致力提供結合實際商業經驗的學術培訓，培育學生擔任領導角色。學院課程涵蓋商業、創業、資訊科技、公共衞生及市場營銷，由行業導師及從業員任教，專為期望獲得教育投資回報、並立志在現今競爭激烈的就業市場中脫穎而出的學生而設。 GBS 位於聖朱利安斯的全新先進校園，致力營造協作學習環境。校園設計仿照現今專業職場，裝備學生所需技能及行業觸覺，助其在需求殷切的領域中盡展所長。 馬耳他是歐洲最安全的國家之一，學生可在此享受優質且學費相宜的教育，以及充滿活力的生活方式。 GBS Malta 是一所經許可的高等教育機構（MFHEA 牌照號碼：2022-010）。其牌照已獲得馬耳他進修與高等教育管理局 (MFHEA) 的批准。MFHEA是一個獨立、透明且具有國際性權威的機構。GBS 的課程同時符合馬耳他資歷框架 (Malta Qualifications Framework) 及歐洲資歷框架 (European Qualification Framework) 的標準。 馬耳他總理 Robert Abela 與 GBS Malta 營運總監（歐洲）Allen Lofaro
IRVINE, Calif., Nov. 20, 2025 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotechnology company developing novel therapies for relapsed and refractory (r/r) B-cell malignancies, announced that two abstracts from its ongoing Phase 1 studies of PMB-CT01 (BAFFR-CAR T) have been accepted for oral presentations at the 2025 American Society of Hematology (ASH) Annual Meeting. The abstracts showcase the emerging safety and efficacy profile of PMB-CT01 in heavily pretreated r/r B-cell Acute Lymphoblastic Leukemia (B-ALL) and r/r B-cell Non-Hodgkin Lymphoma (B-NHL), including patients who failed prior CD19-directed therapy or presented with CD19-negative disease. Interim results from the Phase 1 dose-escalation studies (NCT04690595, NCT05370430) support BAFF-R as a differentiated target designed to overcome CD19 antigen escape while maintaining durable activity and low toxicity. r/r B-NHL Safety:PMB-CT01 demonstrated an exceptionally favorable tolerability profile. No Grade ˃1 Cytokine Release Syndrome (CRS) and no Grade ˃1 Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Efficacy:All the first 7 patients achieved a Complete Response (CR) at 1–3 months post-infusion, including those previously treated with CD19 CAR T therapy and those with CD19-negative disease. Durability:Remissions have remained ongoing for up to 32+ months (median 17 months) at data cutoff. r/r B-ALL Efficacy:Four of six enrolled patients achieved an undetectable Minimal Residual Disease (MRD-) Complete Remission (CR) High-Risk Population:Three of the four responders were CD19-negative at enrollment. All three successfully transitioned to allogeneic hematopoietic cell transplant (HCT) with curative intent. Safety:No Dose-Limiting Toxicities (DLTs) were observed. Only one patient experienced Grade 2 CRS, with no Grade 3 CRS reported. "The consistent and durable activity seen across both B-ALL and B-NHL, particularly in patients who have exhausted CD19 CAR T options or present with CD19-negative disease, strongly supports BAFF-R as a highly effective and safe alternative target," said Hazel Cheng, Ph.D., COO of PeproMene Bio. "These data highlight PMB-CT01's potential to address critical unmet needs in high-risk relapsed disease." ASH 2025 Oral Presentations Abstract Title: BAFFR-CAR T cells demonstrate durable responses and manageable toxicities in r/r B-cell lymphomas… Abstract: abs25-7079Date/Time: December 6, 2:45 PMPresenter: Elizabeth Budde, M.D., Ph.D. Abstract Title: BAFFR-CAR T cells show promising safety and anti-leukemia efficacy in r/r B-cell ALL patients…Abstract: abs25-2035Date/Time: December 8, 11:00 AMPresenter: Ibrahim Aldoss, M.D. (Dates/times are placeholders.) About PMB-CT01 PMB-CT01 is a first-in-class BAFF-R–targeted autologous CAR T cell therapy. BAFF-R is expressed almost exclusively on B cells and is essential for B-cell survival, reducing the likelihood of antigen-loss escape. PMB-CT01 is being evaluated in Phase 1 trials for r/r B-NHL and r/r B-ALL. Forward-Looking Statements This press release contains forward-looking statements subject to risks and uncertainties, including risks related to clinical development, regulatory outcomes, therapeutic potential, and commercialization. PeproMene Bio undertakes no obligation to update forward-looking statements except as required by law. Media/Investor Contact:Hazel Cheng, Ph.D.PeproMene Bio, Inc.Hazel.Cheng@pepromenebio.com
StarCompliance Expense Tracking Connector Now Available in the SAP Concur App Center, Delivering Automated Solution to Firms ROCKVILLE, Md., Nov. 20, 2025 /PRNewswire/ -- StarCompliance (Star), a leading provider of employee and firm compliance technology solutions, today launched an integration with Concur® Expense. Star's Expense Tracking Connector solution provides a streamlined, user-friendly way to manage and reconcile employee expenses, improving accuracy, efficiency, and oversight across the compliance process. "Star's Expense Tracking solution takes automation and accuracy to the next level," said Kelvin Dickenson, Chief Product Officer at Star. "By integrating with leading expense systems like Concur Expense, firms can automatically match reported expenses to pre-cleared declarations in STAR, quickly identify discrepancies, and maintain a complete audit trail within one centralized platform. This streamlines compliance workflows, reduces manual review, and gives teams more time to focus on strategic priorities." Highlights of Star's Expense Tracking solution include: Automated Expense Matching: Integrated with Concur Expense, STAR automatically imports and matches reported expenses to existing declarations, significantly reducing manual review. Discrepancy Resolution: STAR flags expense-declaration mismatches in amount, recipient, company, and venue, enabling quick review and correction by employees and compliance. Time savings through centralization: Downloading and reviewing data across multiple spreadsheets is no longer necessary. Everything is managed within one centralized platform, enabling faster analysis and decision making. Notifications and Tracking: In-app messaging and automated email alerts keep tasks on schedule, while a complete audit trail maintains full visibility into all actions and resolutions. Star's Expense Tracking Connector is now available in the SAP Concur App Center [Link]. About StarCompliance StarCompliance is a leading provider of employee and firm compliance technology solutions. Trusted for over 25 years by millions of users in 120 countries, StarCompliance Enterprise provides a user-friendly interface that delivers the data, technology, and actionable insights needed to proactively mitigate risk, monitor conflicts globally, and support complex whistleblowing regulations. Visit www.starcompliance.com to discover the comprehensive security and unparalleled assurance you need to build a culture of compliance today. SAP and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP SE in Germany and other countries. Please see https://www.sap.com/copyright for additional trademark information and notices. All other product and service names mentioned are the trademarks of their respective companies. Media Contact:Greg.tarmin@starcompliance.com +1 917-868-7791
A12 藝術空間
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
